332 related articles for article (PubMed ID: 14515382)
1. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
2. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
[TBL] [Abstract][Full Text] [Related]
3. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
4. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
Rondinelli PI; Ribeiro Kde C; de Camargo B
J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
[TBL] [Abstract][Full Text] [Related]
5. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
6. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
Offidani M; Corvatta L; Malerba L; Marconi M; Bichisecchi E; Cecchini S; Manso E; Principi T; Gasparini S; Leoni P
Cancer; 2004 Aug; 101(3):567-77. PubMed ID: 15274070
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
[TBL] [Abstract][Full Text] [Related]
10. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
12. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
[TBL] [Abstract][Full Text] [Related]
14. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
16. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
17. Risk of serious bacterial infection in isolated and unsuspected neutropenia.
Melendez E; Harper MB
Acad Emerg Med; 2010 Feb; 17(2):163-7. PubMed ID: 20070267
[TBL] [Abstract][Full Text] [Related]
18. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
19. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.
Macher E; Dubos F; Garnier N; Delebarre M; De Berranger E; Thebaud E; Mazingue F; Leblond P; Martinot A
Pediatr Blood Cancer; 2010 Oct; 55(4):662-7. PubMed ID: 20806364
[TBL] [Abstract][Full Text] [Related]
20. Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
Lüthi F; Leibundgut K; Niggli FK; Nadal D; Aebi C; Bodmer N; Ammann RA
Pediatr Blood Cancer; 2012 Jul; 59(1):90-5. PubMed ID: 21837771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
